Portable scalp cooling to help prevent chemotherapy hair loss
Part of Cancer, Skin clinical trials.
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 21 or older
- You have breast cancer in stage I, II, or III
- You plan to receive a taxane chemotherapy regimen as part of curative (adjuvant or neoadjuvant) treatment
- Your hair from your last chemotherapy hair-loss episode must have fully grown back, at least 2 years ago
- You can complete the planned chemotherapy within 6 months and can attend all study visits
- Your health must be strong enough for study participation (Karnofsky score 80% or higher) and you can sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a cooling cap can help reduce hair loss during chemotherapy for breast cancer. Hair loss can be distressing, and this trial aims to see if the cap helps you keep more hair while still getting the treatment you need.
This Phase 2 trial tests whether using a scalp-cooling device during chemotherapy can help prevent or lessen hair loss in people with metastatic invasive breast cancer. You would need to be starting a specific chemotherapy plan and be willing to begin scalp cooling with your first treatment.
This trial tests whether cooling the scalp during chemotherapy can help reduce chemotherapy-related hair loss. It focuses on people with curly or kinky hair who are having certain cancer treatments, and it checks safety and how much hair loss happens.
This study looks at whether “cold cap” scalp cooling can help prevent or reduce hair loss in children getting chemotherapy. It’s aimed at kids treated with certain chemotherapy medicines and who may be at risk for losing their hair.
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
This study tests whether a cooling cap can prevent hair loss in women receiving specific antibody-drug conjugates (trastuzumab-deruxtecan, sacituzumab-govitecan, or datopotamab-deruxtecan) for advanced solid tumors. If it works, you may keep more of your hair during treatment.
Hear when a new Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.